Over the past 12 months, 1 insider at Aptevo Therapeutics Inc. filed 1 open-market SEC Form 4 transaction on APVO: 1 purchase worth $20K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Nov 10, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 25 | Grady Grant IIIDirector | BUY | 13.5K | $1.49 | $20K |
| Nov 23, 21 | Tang Capital Partners LpOther | SELL | 200.0K | $13.52 | $2.2M |
| Nov 22, 21 | Tang Capital Partners LpTenPercentOwner | SELL | 196.3K | $7.36 | $1.4M |
| Nov 19, 21 | Tang Capital Partners LpTenPercentOwner | SELL | 183.3K | $8.01 | $1.4M |
| Nov 18, 21 | Tang Capital Partners LpTenPercentOwner | SELL | 169.5K | $9.38 | $1.4M |
Over the past 12 months, insiders at Aptevo Therapeutics Inc. filed 1 open-market purchase worth $20K and 0 sales worth $0 on APVO, which makes them net buyers over the period. The most recent Form 4 was filed on Nov 10, 25.
The largest recent open-market APVO insider purchase in our data was $20K by Grady Grant III, Director, filed on Nov 10, 25.
1 different insider at Aptevo Therapeutics Inc. filed open-market SEC Form 4 transactions on APVO over the last 12 months.
InsiderTape plots every APVO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Aptevo Therapeutics Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →